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Abstract
Background: Preterm birth is associated with increased risk of neurological impairment and deficits in cognition,
motor function, and behavioral problems. Limited studies indicate that multi-sensory experiences support brain
development in preterm infants. Music appears to promote neurobiological processes and neuronal learning in
the human brain. Creative music therapy (CMT) is an individualized, interactive therapeutic approach based on
the theory and methods of Nordoff and Robbins. CMT may promote brain development in preterm infants via
concurrent interaction and meaningful auditory stimulation. We hypothesize that preterm infants who receive
creative music therapy during neonatal intensive care admission will have developmental benefits short- and
long-term brain function.
Methods/design: A prospective, randomized controlled single-center pilot trial involving 60 clinically stable preterm
infants under 32 weeks of gestational age is conducted in preparation for a multi-center trial. Thirty infants each are
randomized to either standard neonatal intensive care or standard care with CMT. Music therapy intervention is
approximately 20 min in duration three times per week. A trained music therapist sings for the infants in lullaby
style, individually entrained and adjusted to the infant’s rhythm and affect. Primary objectives of this study are
feasibility of protocol implementation and investigating the potential mechanism of efficacy for this new intervention.
To examine the effect of this new intervention, non-invasive, quantitative magnetic resonance imaging (MRI) methods
at corrected age and standardized neurodevelopmental assessments using the Bayley Scales of Infant and Toddler
Development third edition at a corrected age of 24 months and Kaufman Assessment Battery for Children at 5 years
will be performed. All assessments will be performed and analyzed by blinded experts.
Discussion: To our knowledge, this is the first randomized controlled clinical trial to systematically examine possible
effects of creative music therapy on short- and long-term brain development in preterm infants. This project lies
at the interface of music therapy, neuroscience, and medical imaging. New insights into the potential role and
impact of music on brain function and development may be elucidated. If such a low-cost, low-risk intervention
is demonstrated in a future multi-center trial to be effective in supporting brain development in preterm neonates,
findings could have broad clinical implications for this vulnerable patient population.
Trial registration: ClinicalTrials.gov, NCT02434224.
Keywords: Preterm infants, Brain development, Creative music therapy, Randomized controlled trial, Neurobehavioral
outcomes
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Background
Infants born prematurely (i.e., < 37 weeks gestation) are
a growing patient population representing an important
sector of pediatric health care. Globally, 15 million in-
fants a year are born prematurely [1]. Indeed, approxi-
mately 1 in 10 babies is born prematurely in the USA
and Europe [2]. Notably, preterm birth is a major deter-
minant of both neonatal mortality and morbidity that
can have long-term adverse health consequences. Pre-
mature infants are particularly vulnerable to brain injury,
and preterm birth is associated with reduced white and
gray matter volumes. With regard to gray matter, par-
ticular regions appear to be affected. Decreased thalamic
volume [3], cortical gray matter volume [4], and surface
gyrification [5] have been observed. These abnormalities
are thought to result from periventricular white matter
injury (PWMI)—the predominant form of perinatal brain
injury among preterm infants [6]. Such brain structure
abnormalities persist into later life and have been linked
to a range of neurodevelopmental impairments including
cerebral palsy, motor dysfunction, and cognitive and
behavioral problems as well as deficits in executive
function [7].
Strikingly, those children/adolescents who were born
preterm, yet who have normal intellectual and motor
function, are at increased risk for deficits in executive
function such as attentional control, working memory,
reasoning, and planning [8]. Factors such as environmen-
tal noise and medically required isolation may induce high
levels of stress in preterm infants which may compound
the impaired neurodevelopment [9–11]. It has been pos-
ited that brain maturation is effected by multiple factors.
For instance, the sometimes overwhelming auditory envir-
onment of the neonatal intensive care unit (NICU) may
be problematic while conversely, auditory deprivation
(e.g., the lack of the regular intrauterine rhythms of the
maternal heart beat and the maternal voice) may also
impact maturation [12–14].
Neurobiology of music during early life
A growing area of interest is how interactive, multi-
sensory experiences during fetal life may improve brain
development in the fetus [15–17]. Both human and
animal studies demonstrate that early auditory experi-
ences can influence brain development [18–20]. This is
particularly important following preterm birth as the
plasticity of auditory regions, and cortex development is
heavily dependent on the quality of auditory experiences
[21]. Angelucci and colleagues [22] showed that expos-
ing young adult mice to music can stimulate neuron
development and increased levels of nerve growth factors
in the hippocampus, hypothalamus, and cortical areas.
Thus, it is speculated that positive auditory experience may
promote the preterm infants’ early brain maturation and
contribute to subsequent neurodevelopment [13, 23, 24].
Studies at the interface of music science and neuroscience
have demonstrated that music promotes neurobiological
processes in humans including modulation of synaptic
plasticity, neuronal learning, and neuronal readjust-
ment [25–27]. For instance, music can change the brain
activity in core structures involved in processing emo-
tions [28]. Therefore, it appears that the individualized
approach of live music therapy may activate various
brain regions involved in emotional, sensorimotor, and
cognitive processing, e.g., perception-action mediation
in premotor areas, emotional modulation within the
limbic system, and intentional processes of social cog-
nition in frontal and temporal regions [29–31].
Auditory input appears to be critical for brain matur-
ation development in early life beginning in utero, into the
newborn period, and through early neonatal life. Prior
studies have shown that musical learning begins prior to
birth [32–35] and extensive prenatal exposure to a melody
induces neural representations that can last several
months [36]. In neonates, music stimulation triggers neur-
onal activation in the bilateral front lobes [32]. Moreover,
neuroimaging studies have identified that music activates
limbic and paralimbic regions in the human brain and this
engagement may enhance psychological and physiological
health [37, 38].
Potential benefits of creative music therapy
Creative music therapy (CMT) is an interactive needs-
oriented approach based upon the theory and methods
of Nordoff and Robbins [39]. This framework has been
adapted to address the specific needs of preterm infants
and their parents in the NICU setting [40, 41]. Using
this approach, the music therapist interacts with the
infant through improvised, entrained humming/singing.
The music therapist assesses the infant’s respiration, as
breathing is the most fundamental observable human
rhythm, in concert with the infant’s facial expressions
and gesticulations. The therapist’s response is an infant-
directed, improvised humming that is continually adapted
and tailored to the infant’s needs based on the dynamic
rhythms and subtle expressions of the infant. This often
occurs in a synchronous manner, e.g., when the infant’s
eyebrows lift, the music therapist responds by steering the
melody pitch and tempo upward [41]. Conversely, when
the infant is overly aroused, the therapist may shift the
melody downwards, slowing the tempo to soothe the baby
with calming musical tones [42]. The aim is to keep the
infant-directed humming/singing as simple as possible, as
preterm infants can easily become overstimulated by
sensory stimuli.
The humming is characterized by smooth, fluent melody
contours using rich overtones as in a lullaby and maintain-
ing an infant-directed style. The focus is to keep the music
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calm, simple, predictable, and repetitive—in line with exist-
ing recommendations and guidelines on music therapy in
the NICU setting [43]. Whenever possible, willing parents
are engaged and involved in the therapeutic process, e.g., by
providing music therapy during kangaroo care (i.e., skin-to-
skin holding) and by supporting and encouraging them
to sing to their infant in this responsive and interactive
manner to foster an intuitive parent-infant interaction
contributing to the bonding process. CMT incorporates
psychological models of traumatization and includes tar-
geted interventions to facilitate relaxation, coping and
developing a healthy parent-infant relationship [44].
CMT can be used to calm preterm infants and for re-
spiratory stabilization. Positive music therapy outcomes
(i.e., arousal, behavior, respiratory rate) have been shown
in a multi-site trial as well as in a systematic review and
meta-analysis [45–47]. Our previous work has demon-
strated that the responsive experiences with CMT help
guide infants in engaging in meaningful, nurturing inter-
actions [48].To date, a significant gap in our understand-
ing of CMT has been the paucity of data examining the
effects over time. The recent meta-analysis highlighted
the need for long-term investigation of CMT interven-
tions for neonates implemented by specially trained music
therapists [45]. Indeed, most studies have only focused on
short-term effects, were not randomized or controlled,
and included relatively small sample sizes. Thus, more
rigorous, well-designed studies (i.e., randomized controlled
trials) are warranted to further elucidate the respective
benefits and limitations of CMT in neonatal care.
A critical question is whether or not the individualized
socio-emotional and auditory interactive experiences of
creative music therapy can be quantified in promoting
brain development in preterm infants (Fig. 1). Interest-
ingly, regions for music and language are strongly inter-
connected in the brain [30, 49]. While the mechanism
for such a process is not yet fully elucidated, it is tempting
to speculate that the enriched experience and environ-
ment created by individualized CMT will promote brain
development in preterm infants and that these critical
early developmental events will have developmental bene-
fits in short- and long-term brain function (i.e., language
acquisition).
To address this gap in the field, we conduct a random-
ized controlled pilot trial examining the short- and long-
term neurodevelopmental and neurobehavioral outcomes
of therapeutic CMT treatment. We hypothesize that com-
pared to controls, preterm neonates receiving the CMT
intervention will demonstrate:
 Improved brain growth and development at 38–
42 weeks (corrected gestational age) as evidenced by
 Greater global and regional brain volumes
measured by 3D volumetric magnet resonance
imaging (MRI)
 Enhanced white matter microstructure (higher
fractional anisotropy)
 Improved functional network development
 Improved cognitive, behavioral and motor
developmental outcome at 24 months and 5 years
in terms of adaptive skills, executive function, and
language abilities using validated metrics.
Methods
Design and setting
The pilot study is designed as a prospective, single-center,
randomized, controlled clinical trial in preparation for a
full-scale trial. Since this is the first study to evaluate pos-
sible effects of CMT on neurobehavioral outcomes in pre-
term infants, a pilot design is chosen to test its clinical,
recruitment, and outcome measurement feasibility [50]. In
total, 60 preterm infants will be included in the study
Fig. 1 Factors leading to the development of hypotheses
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since a minimum of 30 participants for each arm in pilot
studies is recommended in order to estimate parameters
for future sample size calculations [50, 51].
The inclusion criteria are as follows: gestational age at
birth < 32 weeks (due to a necessary time frame of 4 weeks
at a minimum for music therapy treatment), chronological
age ≥ 7 days of life, and clinically stable and signed, written
parental informed consent. Neonates with a genetically
defined syndrome, congenital malformation (adversely
affecting life expectancy or neurodevelopment), moderate/
severe intraventricular hemorrhage, congenital hearing
loss, or those infants admitted for palliative care are ex-
cluded from the study. Preterm neonates are excluded
from the control group in situations when infants are
exposed to regular singing (or other kinds of music stimu-
lation) from parents during hospitalization.
All parents of neonates meeting the inclusion criteria
are asked by the investigator to participate in the study
within the second weeks after birth, i.e., day of life 7–14
(Additional file 1). Following signed informed consent
(Additional file 2), randomization is performed using a
computer-generated list created prior to study initiation
(Table 1). Neonates randomized to the control group
receive standard care as delivered by the Department of
Neonatology at the University Hospital of Zurich. Of
note, and as stated in the exclusion criteria, standard
neonatal care does not include any type of music stimu-
lation for the preterm infant.
The intervention
Experimental group infants receive the CMT intervention.
The individualized therapeutic approach is delivered as
initially reported [48] and as described above. CMT ther-
apy is initiated immediately following the parental con-
sent. Therapy sessions are delivered three times per week
mostly in the morning until discharge by a music therapist
(FH). To ensure the safety of the infants, the chosen study
music therapist is a well-trained and experienced music
therapist with specialized competencies, sensitivity, and
responsiveness in neonatal music therapy [52]. CMT with
premature infants is based upon the premise that infants
should be neither overwhelmed nor over-stimulated [41].
However, in the case the infants would show adverse
reactions (e.g., unexpected strong apnea, bradycardia, hyp-
oxia) during the music therapy intervention, the music
therapist would adapt or stop the treatment immediately.
Moreover, the nurse in charge continuously monitors the
therapy process to additionally guarantee the safety of the
participants.
Individualized, culturally adapted treatment plans are
formulated based on an initial child-parent assessment in-
cluding consideration of stated parental needs, musical
heritage, culture, context, and desire for integration into
the therapeutic process. Emphasis is placed on providing a
supporting role rather than assuming a directive, educa-
tional, or corrective role with respect to parental compe-
tencies and autonomy. In general, each CMT intervention
lasts approximately 20 min. Duration is adapted according
to infant needs and development—both immediate and
evolving. We expect sessions increase in length as the
infant matures. The exact number, time, and duration of
sessions are documented in the individual session protocol
and final report (Additional file 3). To maintain study
enrollment, neonates randomized to receive the CMT
intervention must receive a minimum of ten sessions of
CMT—which is the number of sessions needed to meas-
ure an effect of the therapy [42, 43]. Prior to hospital dis-
charge, the music therapist provides a final consultation
and debriefing discussion with the parents including
therapeutic recommendation and offering music therapy
consultation for the first year of life.
Preterm infants have to be excluded from the study if
they are not stable enough for CMT treatment and/or
would show serious behavioral or physiological signs of
overstimulation or other adverse reactions during or after
the music therapy intervention. Moreover, the sponsor
continuously monitors the therapy process to guarantee
the safety of the participants. The sponsor can terminate
the study within its area of responsibility in the case of
threatening the patient’s well-being and safety. Under
such circumstances, the ethics committee will be in-
formed immediately.
Minimizing bias
The music therapy process is documented by the music
therapist in a standardized form (Additional file 3) in
Table 1 Course and outcome measures of music trial
Screening Enrollment and allocation Outcome measures
Birth until DOL 7 DOL 7–14 DOL 8 until discharge At TEA CGA 24 months CGA 5 years
Inclusion and
exclusion criteria
Informed consent
Randomization
Intervention group:
CMT 3×/week and
standard care control
group: standard care
Brain MRI BSID-III Kaufman ABC
cUS cUS weekly Neurological examination Neurological examination
Clinical records for
morbidities, SES
Clinical records for
morbidities, SES
Parental questionnaire Parental questionnaire
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detailed reflections depicting methodical and therapeutic
procedures as well as notes recording parental involve-
ment, environmental circumstances, and additional ob-
jective physiologic measures (respiration and heart rate,
oxygen saturation) recorded by ongoing electronic moni-
toring. An independent study nurse randomly monitors
this process to minimize bias. To maintain blinding for
the subsequent long-term follow-up assessment (at 2
and 5 years) of primary and secondary neurodevelop-
mental outcomes, no notes of the CMT are entered into
the medical record.
Central randomization was performed by the Clinical
Trial Center Zurich on the basis of randomization lists.
Selection bias is minimized with allocation concealment
and random sequence. Sealed, opaque, numbered enve-
lopes are opened sequentially only after the envelope has
been irreversibly assigned to the participant. The alloca-
tion process is monitored by the study sponsor to pre-
serve concealment. In the event that standard care for
an infant in the control group could be contaminated
(i.e., intervention and control have adjacent cribs), the
neonate in the control group receives hearing protection
via ear plugs and special headsets for premature infants
placed during the music therapy session. The hearing
protection device employed for this purpose effectively
blocks 20–30 dB of environmental sound. This corre-
sponds with the highest possible decibel level produced
at the bedside during the music therapy intervention
(measured with “dB Volume, DSP Mobile, Iphone App”).
Prior to discharge, parents of infants in the control
group are interviewed if infants were exposed to singing
or another kind of music stimulation during hospitalization.
Only the control infants who have received no humming/
singing/musical stimulation are included in the analysis as
the comparison group. The study protocol received ap-
proval by the independent SwissPharmAudit (audit no.:
CTCQA14).
Outcomes
The primary objective of this study is feasibility of protocol
implementation, including the estimation of drop-out rate
and differential drop-out rate within treatment groups, and
further objectives of the study are investigating the potential
mechanisms of efficacy for this new intervention. The po-
tential mechanisms of efficacy are measured with cerebral
magnetic resonance imaging and neurodevelopmental out-
come at corrected 2 and 5 years of age.
Advantages of using MRI are that it is non-invasive,
quantitative, sensitive measurement. Microstructure of
the white matter is assessed using tract-based spatial statis-
tics (TBSS), an automated, observer-independent method
for assessing fractional anisotropy in the major white mat-
ter tracts on a voxel-wise basis across groups of subjects
[9]. TBSS has been used to identify subtle group differences
in studies of patients with birth weight [53] or neuro-
protective interventions [54]. Brain morphology is assessed
both globally (intracranial cavity, cerebellum, brainstem,
two hemispheres) and at the tissue level (cortical and sub-
cortical gray matter, myelinated and unmyelinated white
matter, cerebrospinal fluid) segmentation [55] to evaluate
group differences. Functional and structural connectivity is
compared between the groups using diffusion tensor im-
aging (DTI) and resting state functional magnetic reson-
ance imaging (rsFMRI).
Neurodevelopmental and neurological outcome will be
assessed with (Table 1):
 Bayley Scales of Infant and Toddler Development III
(BSID-III) including mental development index and
psychomotor development index assessment [56]
 Neurological exam (including classification of cerebral
palsy in Europe) and Palisano’s gross motor function
classification [57, 58]
 Visual and hearing exam [59]
 Adaptive Behavior Assessment System (ABAS)-II
parental questionnaire which is a comprehensive
assessment of daily adaptive skills necessary for
functioning effectively and navigating one’s environment
based on typical demands according to age [60]
Additionally, a parental questionnaire assessing the in-
fant’s exposure to music is administered.
Since there is a substantial gap in present knowledge
to assess the long-term impact of music therapy in
preterm infants [45], and since at 2 years of age merely
developmental milestones can be measured while more
complex cognitive functions such as executive functions
are only developing, we assess neurodevelopmental out-
comes also at 5 years of corrected age [61]. Along these
lines, it was recently postulated that the 2-year outcome
should be used as a proof for safety of neuroprotective
agents rather than their efficacy [61]. Hence, following
tests will be performed at 5 years of corrected age re-
lating to six main neurobehavioral outcomes including
(Table 1):
 Kaufman Assessment Battery for Children (KABC)-II
[62] to evaluate cognitive development
 Neurological exam with cerebral palsy qualification
and Palisano’s gross motor function classification [57]
 Behavior exam: Strengths and Difficulties Questionnaire
(SDQ) evaluating physical limitations [63]
 Gross motor exam “Zürcher Neuromotorik” to
assess balance, gaits, speed, and mirror overflow
(referred to as “associated movements,” AM) [57]
 Assessments of visual problems such as corrective
glasses, strabism, severe visual impairment, or
blindness [64]
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 Assessment of hearing problems such as moderate
hearing impairment not requiring hearing aids or
cochlear implant [64]
 Parental questionnaires:
 Adaptive Behavior Assessment System (ABAS)-II
for assessing of daily adaptive skills [60]
 Behavior Rating Inventory of Executive Function
- Preschool Version (BRIEF-P) to report on
executive function abilities [65]
Additionally, a parental questionnaire about their (mu-
sical) education of their infant will be distributed.
All listed neurobehavioral outcomes from 18 months
to 5 years except the parental questionnaires ABAS-II
and BRIEF-P are validated routine assessments within
the Swiss Neonatal Network. These assessment tools
have been standardized for follow-up assessments and
are used by child development specialists in Switzerland
since 2006 and thus reflect Swiss consensus on optimal
follow-up assessment for premature infants [64]. These in-
struments are accepted and widely used within the Swiss
Neonatal Network (http://www.neonet.ch/en/). To ensure
high follow-up rates, all parents of premature infants are in-
vited to the compulsory follow-up examinations through
the nationwide follow-up network.
Demographic data, medical information, and the socio-
emotional status of the parents are documented in the
case report form. Serial cerebral ultrasound (cUS) is used
to detect, confirm, and monitor brain damage (Table 1).
At follow-up, a blinded developmental pediatrician, who is
not informed if the infant has received music therapy or
not, conducts the measurements.
Statistical analysis
The primary objective of this study is feasibility including
the estimation of drop-out rate and differential drop-out
rate within treatment groups. Time points for the evalu-
ation of drop-out rates will be at 38–42 weeks and at
2 years. Drop-out rates and their corresponding confi-
dence intervals will be estimated using the Wilson method
[66].The success of recruitment will also be measured by
summarizing randomization rates and reasons of with-
drawal compared to available patients listed in the screen-
ing log. We anticipate differential protocol adherence with
respect to treatment group assigned.
To test the effect of the intervention, point estimates
of mean differences for efficacy will be estimated with
corresponding 95% confidence interval for continuous
outcomes, and differences in proportions with 95%
confidence interval for the two treatment groups will be
calculated for categorical outcomes. Univariate analysis
of covariance (ANCOVA) will be performed to examine
MRI differences between the groups. The independent
variables are treatment group and gender. Resulting
estimates of mean differences and differences in propor-
tions including variability will serve to perform the sam-
ple size calculation for the multi-center full-scale trial.
Discussion
Our initial experience with recruiting and consenting
the parents has revealed parental concerns regarding the
fact that their infant could end up in the control group
and would not receive the music therapy intervention.
Indeed, for some, this was a motivating factor not to
participate in the study. We also had to exclude some
control infants from the study because the parents
started to intuitively sing to their infants (or they previ-
ously done so on a regular basis). These potential con-
founders highlight the value that many parents place on
music therapy and the role of singing in interactions
with their babies and the bonding process as previously
reported in the literature [48, 67].
Although approximately 120 preterm infants under 32
SSW are treated in the unit every year, recruiting time is
much longer as expected since approximately 60% of the
patients treated in our unit are from other countries and
cultures and study participation is often limited because
of language and ethnical barriers [68]. Culturally congru-
ent study information available in other languages may
reduce some of these barriers in future investigations,
and a multi-center study is warranted to recruit enough
participants for a full-scale trial in an appropriate time
span. Also, infants with severe brain injury such as intra-
ventricular hemorrhage (grades III–IV) or cystic white
matter injury are not included into the study.
It is worthwhile to note that double-blinding was not
possible given the intervention design. The goal is to
evaluate responsive, interactive live music therapy rather
than simply comparing a standardized-recorded auditory
stimulus which could be relatively easy to conduct using
double-blind headphones with/without music stimulus.
Indeed, neurobehavioral development is thought to be
accelerated by nurturing, social learning experiences,
and human interaction as opposed to machine-based in-
teractions [42, 69].
To our knowledge, this is the first randomized con-
trolled clinical trial to systematically investigating the
potential short- and long-term effects of CMT on brain
development in preterm infants. This project lies at the
interface of music therapy, neuroscience, and medical
imaging. New insights into the potential role and impact
of music on brain function and development may be elu-
cidated by this study. If such a low-cost, low-risk inter-
vention is demonstrated in a future multi-center trial to
be effective in supporting brain development in preterm
neonates, findings could have broad clinical implications
for this vulnerable patient population.
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